17K11118/Japan Society for the Promotion of Science[Grants and Funding] - Search Results

Year	Number of Results
2018	9
2019	6
2024	0

1

Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.

Iwamura H, Hatakeyama S, Sato M, Ohyama C. Iwamura H, et al. Med Oncol. 2018 May 9;35(6):94. doi: 10.1007/s12032-018-1152-1. Med Oncol. 2018. PMID: 29744601 Free PMC article. Review.

2

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C. Konishi S, et al. Med Oncol. 2018 Nov 24;36(1):6. doi: 10.1007/s12032-018-1231-3. Med Oncol. 2018. PMID: 30474747

3

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Okamoto T, et al. World J Urol. 2019 Sep;37(9):1827-1835. doi: 10.1007/s00345-018-2590-2. Epub 2018 Dec 4. World J Urol. 2019. PMID: 30511214

4

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C. Hamano I, et al. Clin Exp Nephrol. 2019 Jun;23(6):807-813. doi: 10.1007/s10157-019-01710-z. Epub 2019 Feb 27. Clin Exp Nephrol. 2019. PMID: 30809748

5

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C. Horiguchi H, et al. Med Oncol. 2018 Feb 26;35(4):41. doi: 10.1007/s12032-018-1102-y. Med Oncol. 2018. PMID: 29480348

6

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C. Fujita N, et al. Int Urol Nephrol. 2018 Nov;50(11):1999-2005. doi: 10.1007/s11255-018-1985-8. Epub 2018 Sep 18. Int Urol Nephrol. 2018. PMID: 30229466

7

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C. Kido K, et al. Int J Clin Oncol. 2018 Aug;23(4):726-733. doi: 10.1007/s10147-018-1248-9. Epub 2018 Feb 12. Int J Clin Oncol. 2018. PMID: 29435873

8

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C. Okita K, et al. Med Oncol. 2018 Nov 26;36(1):7. doi: 10.1007/s12032-018-1232-2. Med Oncol. 2018. PMID: 30478763

9

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Tanaka T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C. Hamano I, et al. Int J Urol. 2018 Sep;25(9):817-824. doi: 10.1111/iju.13732. Epub 2018 Jul 2. Int J Urol. 2018. PMID: 29963714

10

Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

Hamano I, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Hamano I, et al. World J Urol. 2019 Nov;37(11):2365-2373. doi: 10.1007/s00345-019-02664-3. Epub 2019 Feb 7. World J Urol. 2019. PMID: 30729312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year